2024 Annual Meeting | S43 - General Neurology 2

Date Thursday 04/18/24

Time 01:00 PM - 03:00 PM MDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Scientific Platform Session

Moderator(s) Fatima Traore, MD, Lucas Restrepo, MD, PhD

Topic(s) General Neurology

Learning Objectives A group of abstracts covering a similar topic will be presented in an eight-minute oral format followed by four minutes of question and answer with the author.

CME Available 2.00 CME credits

Program Evaluations

Event Timeline
01:00 PM - 01:12 PM MDT	Abstract	001 - Progression of Nonfluent Primary Progressive Aphasia and Primary Progressive Apraxia of Speech into Corticobasal Syndrome Danna P. Garcia-Guaqueta, MD
01:12 PM - 01:24 PM MDT	Abstract	002 - Takotsubo Cardiomyopathy: A Brain Network that Breaks Your Heart Frederic Schaper, MD, PhD
01:24 PM - 01:36 PM MDT	Abstract	003 - Smoking Is Associated with Accelerated Brain Aging: A Large, Diverse Population-based Analysis Soojin Lee
01:36 PM - 01:48 PM MDT	Abstract	004 - Novel Bispecific Degrader BHV-1300 Achieves Rapid, Robust, and Selective IgG Reduction in Preclinical Models Including Nonhuman Primates Anna Bunin
01:48 PM - 02:00 PM MDT	Abstract	005 - Smartphone Monitoring of Multidomain Gait Parameters to Facilitate Remote Monitoring of Gait in Idiopathic Normal Pressure Hydrocephalus Aida Kamalian, MD, MPH
02:00 PM - 02:12 PM MDT	Abstract	006 - Continuous Monitoring of Upper Limb Function in Neurological Disorders Using a Wearable Sensor Adonay Nunes
02:12 PM - 02:24 PM MDT	Abstract	007 - Disease Burden of Neurological Disorders in Underserved Populations Across the US in 2022 Nikki Win
02:24 PM - 02:36 PM MDT	Abstract	008 - Anesthetic Effects on Neuronally-based Resting-state Functional Connectivity James H. Lai
02:36 PM - 02:48 PM MDT	Abstract	009 - The Role of Specific Gut Microbiome Populations in Modulating Disease in the SOD-1 Mode of Amyotrophic Lateral Sclerosis (ALS) Megha Kaul
02:48 PM - 03:00 PM MDT	Abstract	010 - Digital Speech Assessments in Huntington Disease Ashkan Vaziri, PhD

Faculty Disclosures
Zachary Simmons, MD, FAAN	Dr. Simmons has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amylyx. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clene. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Insmed. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Simmons has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Corcept. The institution of Dr. Simmons has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley. The institution of Dr. Simmons has received research support from MGH. The institution of Dr. Simmons has received research support from Clene. The institution of Dr. Simmons has received research support from NIH via MGH. The institution of Dr. Simmons has received research support from Aburo. The institution of Dr. Simmons has received research support from NIH subaward via Univ of Pennsylvania.
Howard L. Weiner, MD	Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Weiner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tiziana Life Sciences. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for vTv Therapeutics. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medday Pharmaceuticals. Dr. Weiner has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for vTv Therapeutics. Dr. Weiner has stock in vTv Therapeutics. The institution of Dr. Weiner has received research support from National Institute of Health. The institution of Dr. Weiner has received research support from National MS Society. The institution of Dr. Weiner has received research support from Genzyme Corp. The institution of Dr. Weiner has received research support from Genentech, Inc. . The institution of Dr. Weiner has received research support from Verily Life Sciences LLC. The institution of Dr. Weiner has received research support from EMD Serono, Inc..
Reinhard Hohlfeld, MD	Dr. Hohlfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis .
David R. Lynch, MD, PhD	The institution of Dr. Lynch has received research support from reata. The institution of Dr. Lynch has received research support from PTC. Dr. Lynch has received intellectual property interests from a discovery or technology relating to health care.
Cenk Ayata, MD	Dr. Ayata has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Quris. Dr. Ayata has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurelis. The institution of Dr. Ayata has received research support from NIH. The institution of Dr. Ayata has received research support from Takeda. The institution of Dr. Ayata has received research support from Neurelis.
Ralf Gold, MD	Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Lucas Restrepo, MD, PhD	Dr. Restrepo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Restrepo has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly USA. Dr. Restrepo has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Kelvi/Hypothermia Devices, Inc.. Dr. Restrepo has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Journals, The Neurohospitalist. Dr. Restrepo has stock in Hypothermia Devices, Inc. (dba Kelvi). Dr. Restrepo has stock in Eli Lilly. Dr. Restrepo has received intellectual property interests from a discovery or technology relating to health care.
Keith A. Josephs, Jr., MD, FAAN	Dr. Josephs has nothing to disclose.
Natalia S. Rost, MD, MPH, FAAN, FAHA	Dr. Rost has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for ��ɫ��. Dr. Rost has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke - AHA/ASA Journal. The institution of Dr. Rost has received research support from NIH. Dr. Rost has received publishing royalties from a publication relating to health care.
Abhay Moghekar, MD	Dr. Moghekar has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Deluca and Weizenbaum. Dr. Moghekar has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Silver Golub and Tieteel. Dr. Moghekar has a non-compensated relationship as a Medical Advisory Board member with Hydrocephalus Association that is relevant to AAN interests or activities. Dr. Moghekar has a non-compensated relationship as a Medical Advisory Board member with Spinal CSF Leak Foundation that is relevant to AAN interests or activities.
Mary M. Machulda, PhD	The institution of Dr. Machulda has received research support from NIH.
E. Ray Dorsey, MD, MBA	Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Seelos Therapeutics. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eden McCallum, LLP. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for WebMD. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioSensics. Dr. Dorsey has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Mediflix. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerevance. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kairos Cinema, LLC. Dr. Dorsey has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America Inc.. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra. Dr. Dorsey has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medrhythms. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ANA. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for HMP ��ɫ��, LLP. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ADIVO Associates France. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for University of Toronto. Dr. Dorsey has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Philadelphia Neurological Society. Dr. Dorsey has stock in Included Health. Dr. Dorsey has stock in Mediflix. Dr. Dorsey has stock in SemCap. Dr. Dorsey has stock in Synapticure. The institution of Dr. Dorsey has received research support from NIH/NINDS. The institution of Dr. Dorsey has received research support from Burroughs Wellcome . The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Fox Insight. The institution of Dr. Dorsey has received research support from Michael J. Fox Foundation - Emerald. The institution of Dr. Dorsey has received research support from B. Thomas Golisano Foundation. The institution of Dr. Dorsey has received research support from Emerald Innovations, Inc.. The institution of Dr. Dorsey has received research support from Photopharmics Inc.. The institution of Dr. Dorsey has received research support from Averitas Pharma Inc.. The institution of Dr. Dorsey has received research support from DOD/Army Medical Research Acquisition Activity. The institution of Dr. Dorsey has received research support from NIH/NINDS.
Irfan Qureshi, MD	Dr. Qureshi has received personal compensation for serving as an employee of Biohaven. Dr. Qureshi has stock in Biohaven Pharmaceuticals.
Stephen Krieger, MD, FAAN	Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Krieger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Krieger has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Expert Witness. The institution of Dr. Krieger has received research support from Novartis. The institution of Dr. Krieger has received research support from Bristol Myers Squibb. The institution of Dr. Krieger has received research support from Biogen.
Michael D. Fox, MD, PhD	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.
Kerstin Hellwig	Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mylan . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Kerstin Hellwig has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Merck . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis . Kerstin Hellwig has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche . The institution of Kerstin Hellwig has received research support from Roche . The institution of Kerstin Hellwig has received research support from Merck . The institution of Kerstin Hellwig has received research support from Biogen. The institution of Kerstin Hellwig has received research support from Genzyme . The institution of Kerstin Hellwig has received research support from Novartis . The institution of Kerstin Hellwig has received research support from BMS .
Jennifer Whitwell, PhD	Dr. Whitwell has nothing to disclose.
Jamie L. Adams, MD	Dr. Adams has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Adams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Michael J. Fox Foundation. Dr. Adams has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BioSensics. The institution of Dr. Adams has received research support from NIH/NINDS. The institution of Dr. Adams has received research support from Biogen. The institution of Dr. Adams has received research support from The Michael J. Fox Foundation. The institution of Dr. Adams has received research support from Critical Path Institute. Dr. Adams has received personal compensation in the range of $500-$4,999 for serving as a KINECT-HD Steering Committee Member with Huntington Study Group. Dr. Adams has received personal compensation in the range of $500-$4,999 for serving as a ORCHESTRA-PD Steering Committee Member with Parkinson Study Group.
Vladimir Coric	Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
David Y. Chung, MD	Dr. Chung has received research support from NIH/NINDS. Dr. Chung has received research support from The Aneurysm and AVM Foundation.
Joachim Havla, MD	Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Havla has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Havla has received research support from Merck.
Robert Hoepner	Robert Hoepner has nothing to disclose.
Hugo Botha, MD	Dr. Botha has received research support from NIH.
	No disclosure on file
Fatima Traore, MD	Dr. Traore has nothing to disclose.
Aida Kamalian, MD, MPH	Dr. Kamalian has nothing to disclose.
Meghan E. Pawlik, MS	Miss Pawlik has nothing to disclose.
Nikki Win	Nikki Win has received personal compensation for serving as an employee of Genentech. Nikki Win has stock in Genentech .
Anisha Patel, PhD	Dr. Patel has received personal compensation for serving as an employee of Genentech. An immediate family member of Dr. Patel has received personal compensation for serving as an employee of Google. Dr. Patel has stock in Genentech Inc.. An immediate family member of Dr. Patel has stock in Google.
Frederic Schaper, MD, PhD	Dr. Schaper has nothing to disclose.
Ashkan Vaziri, PhD	Dr. Vaziri has received personal compensation for serving as an employee of Biosensics.
Raj Attariwala, MD, PhD	Dr. Attariwala has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Prenuvo. Dr. Attariwala has stock in Prenuvo. Dr. Attariwala has received research support from Voxelwise Imaging Technology. Dr. Attariwala has received personal compensation in the range of $100,000-$499,999 for serving as a Radiologist reading cases and helping build in house software tools with Prenuvo.
Elizabeth Mearns, PhD	Dr. Mearns has received personal compensation for serving as an employee of Genentech. Dr. Mearns has stock in Genentech.
Sam Hashemi	Mr. Hashemi has received personal compensation for serving as an employee of Prenuvo.
James H. Lai	Mr. Lai has nothing to disclose.
Danna P. Garcia-Guaqueta, MD	Dr. Garcia-Guaqueta has nothing to disclose.
Laura M. Cox	Dr. Cox has received personal compensation for serving as an employee of Anaerobe Systems.
Soojin Lee	No disclosure on file
Megha Kaul	No disclosure on file
Bruce D. Car	Dr. Car has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Car has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PathAI. Dr. Car has stock in BHVN. Dr. Car has received intellectual property interests from a discovery or technology relating to health care.
Anna Bunin	Dr. Bunin has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Bunin has stock in Biohaven Pharmaceuticals. Dr. Bunin has received intellectual property interests from a discovery or technology relating to health care.
Joseph Duffy	The institution of Joseph Duffy has received research support from NIH. Joseph Duffy has received publishing royalties from a publication relating to health care.
Heather Clark	The institution of Heather Clark has received research support from NIH. Heather Clark has received publishing royalties from a publication relating to health care.
Andrew Geronimo	The institution of Andrew Geronimo has received research support from BIoSensics.
Rene Utianski	Rene Utianski has nothing to disclose.
Gene Dubowchik	Gene Dubowchik has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Gene Dubowchik has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Morrison Foerster.
Tao Qin	No disclosure on file
Ona Wu	The institution of Ona Wu has received research support from NIH. Ona Wu has received intellectual property interests from a discovery or technology relating to health care. Ona Wu has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH.
Ram Kinker Mishra	Ram Kinker Mishra has received personal compensation for serving as an employee of BioSensics LLC.
Saurabh Garg	No disclosure on file
Yosef Chodakiewitz	No disclosure on file
Nasrin Akbari	No disclosure on file
Thanh Nguyen	No disclosure on file
Adonay Nunes	Adonay Nunes has nothing to disclose.
Jose Casado	Jose Casado has received personal compensation for serving as an employee of Biosensics.
Madhurima Datta	No disclosure on file
Katherine Rosettie	No disclosure on file
Stacey Kowal	No disclosure on file
Arun Rajendran	No disclosure on file
Anny Zheng	No disclosure on file
Nima Dana	No disclosure on file
David Pirman	David Pirman has received personal compensation for serving as an employee of Biohaven. David Pirman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scaffold Tx. David Pirman has stock in Agios.
Kyuree Kim	No disclosure on file
Neal Sharpe	Neal Sharpe has nothing to disclose.
David Boas	No disclosure on file
Ann Marie ROSSI	No disclosure on file
Mae Morton-Dutton	No disclosure on file
Wes Kazmierski	Wes Kazmierski has received personal compensation for serving as an employee of Biohaven Phamaceuticals. Wes Kazmierski has stock in Biohaven Pharmaceuticals. Wes Kazmierski has received intellectual property interests from a discovery or technology relating to health care.
Kathleen McGrath	Kathleen McGrath has received personal compensation for serving as an employee of Biohaven . Kathleen McGrath has stock in Biohaven.
Seong Lee	Seong Lee has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Seong Lee has stock in Biohaven Pharmaceuticals.
David Spiegel	David Spiegel has received personal compensation in the range of $500,000-$999,999 for serving as a Consultant for Biohaven. David Spiegel has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Magnet Biotherapeutics. David Spiegel has stock in Biohaven. David Spiegel has stock in Magnet Biotherapeutics. The institution of David Spiegel has received research support from Biohaven. David Spiegel has received intellectual property interests from a discovery or technology relating to health care.
Elizabeth Dierks	Elizabeth Dierks has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Elizabeth Dierks has stock in Biohaven Pharmaceuticals. Elizabeth Dierks has stock in Bristol-Myers Squibb.
Sava Sakadzic	No disclosure on file
Austin Goodrich	No disclosure on file
Simone Nicholson	Simone Nicholson has received personal compensation for serving as an employee of Biohaven. Simone Nicholson has stock in Biohaven.

��ɫ����

��ɫ����

��ɫ��

��ɫ��